RN7SL369P

Across TCGA pan-cancer cohorts, RN7SL369P RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated RN7SL369P data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher RN7SL369P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL369P expression acts as an unfavorable survival marker, although some lineages such as LIHC and KIRC show a favorable association.

DLBC, THYM, and ESCA are the cancer types where RN7SL369P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	OS	Tertile	II,III,IV	0.172	0.949	<.001	54	view →
THYM	OS	Tertile	All	0.746	0.982	<.001	48	view →
ESCA	OS	Tertile	IV	0.127	0.571	.003	45	view →
LIHC	DFS	Tertile	All	0.681	0.263	.001	27	view →
UVM	OS	Tertile	III,IV	0.230	0.830	.001	24	view →
KIRC	DFS	Tertile	All	0.947	0.766	.013	24	view →
MESO	DFS	Tertile	All	0.210	0.405	.021	18	view →
PAAD	OS	Tertile	II,III,IV	0.353	0.634	.018	18	view →
UCEC	DFS	Tertile	III,IV	0.266	0.584	.011	18	view →
LAML	DFS	Tertile	All	0.319	0.597	.003	18	view →
UCS	OS	Tertile	All	0.323	0.589	.035	12	view →
ACC	OS	Tertile	III,IV	0.414	0.816	.005	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

RN7SL369P–DLBC (OS)

Open the DLBC breakdown →